VCRC5502: Longitudinal Protocol for Giant Cell Arteritis

Request Access

Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis

P. Grayson, K. Maksimowicz-McKinnon, T. Clark, et al.. (2012). Annals of the Rheumatic Diseases. Cited 241 times. https://doi.org/10.1136/annrheumdis-2011-200795

Pneumocystis jiroveci pneumonia in giant cell arteritis: A case series

T. Kermani, S. Ytterberg, K. Warrington. (2011). Arthritis Care & Research. Cited 46 times. https://doi.org/10.1002/acr.20435

Association of a nonsynonymous single-nucleotide polymorphism of matrix metalloproteinase 9 with giant cell arteritis.

Alicia Rodríguez-Pla, Terri H. Beaty, P. J. Savino, et al.. (2008). Arthritis and rheumatism. Cited 40 times. https://doi.org/10.1002/art.23457

Recent Advances in Diagnostic Strategies for Giant Cell Arteritis

T. Kermani, K. Warrington. (2012). Current Neurology and Neuroscience Reports. Cited 26 times. https://doi.org/10.1007/s11910-011-0243-6

Lower extremity vasculitis in polymyalgia rheumatica and giant cell arteritis

T. Kermani, K. Warrington. (2011). Current Opinion in Rheumatology. Cited 25 times. https://doi.org/10.1097/BOR.0b013e3283410072

MMP-12, a novel matrix metalloproteinase associated with giant cell arteritis.

Alicia Rodríguez-Pla, F. Martínez-Murillo, P. Savino, et al.. (2009). Rheumatology. Cited 16 times. https://doi.org/10.1093/rheumatology/kep271
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747